Inventor · disambiguated record
Thomas J. Blacklock
Also filed as: BLACKLOCK THOMAS · BLACKLOCK THOMAS J
17 granted patents·7 pending applications·299 citations·filing 1983–2024
95Inventor score
Top patents by PatentIndex Score
24 records- 0196US8877938B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2006·Granted Nov 4, 2014·44 cites·14 claims
- 0291US2025339395A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2024·Application pending·0 cites
- 0390US5612478AProcess for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecaneJOHNSON MATTHEY PLC·Filed 1995·Granted Mar 18, 1997·45 cites·19 claims
- 0486US9388134B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2014·Granted Jul 12, 2016·5 cites·15 claims
- 0584US11642329B2Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Granted May 9, 2023·0 cites·2 claims
- 0683US5801281AProcess for preparing 1,1'- (1,4- phenylenebis (methlene)-Bis 1,4,8,11-tetraazacyclotetradecaneJOHNSON MATTHEY PLC·Filed 1997·Granted Sep 1, 1998·22 cites·3 claims
- 0783US2022257551A1Amorphous solid form of compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Application pending·0 cites
- 0881US11096918B2Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 0980US5756728AProcess for preparing 1,1'- 1,4-phenylenebis-(methylene)!-bis-1,4,8,11-tetraazacyclotetradecaneJOHNSON MATTHEY PLC·Filed 1996·Granted May 26, 1998·19 cites·5 claims
- 1079US5157129AEnantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxideMERCK & CO INC·Filed 1990·Granted Oct 20, 1992·23 cites·28 claims
- 1179US2021361610A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2021·Application pending·0 cites
- 1278US5189177AChiral boron catalysts for reduction of ketones and process for their preparationMERCK & CO INC·Filed 1991·Granted Feb 23, 1993·19 cites·11 claims
- 1378US5039802AArylation process for preparation of chiral catalysts for ketone reductionMERCK & CO INC·Filed 1990·Granted Aug 13, 1991·20 cites·7 claims
- 1477US4510083AProcess for preparing polypeptidesMERCK & CO INC·Filed 1983·Granted Apr 9, 1985·33 cites·4 claims
- 1574US5264585AChiral catalysts for reduction of ketones and process for their preparationMERCK & CO INC·Filed 1992·Granted Nov 23, 1993·15 cites·4 claims
- 1672US2019374498A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1772US2019374497A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1870US4992541AProcess for the preparation of 1,1-dioxo-7-substituted cephemsMERCK & CO INC·Filed 1989·Granted Feb 12, 1991·10 cites·6 claims
- 1970US4968815ASynthesis of (S)-3-(thien-2-ylthio)butyric acid analogsMERCK & CO INC·Filed 1990·Granted Nov 6, 1990·11 cites·4 claims
- 2069US2018344679A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2162US2016324821A1Compounds containing s-n-valeryl-n--valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2016·Application pending·0 cites
- 2260US4968814A(S)-Alkyl 3-(thien-2-ylthio)butyrate and analogs and synthesis thereofMERCK & CO INC·Filed 1990·Granted Nov 6, 1990·15 cites·4 claims
- 2356US5688968AEnantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno 2,3-B!thiopyran-2-sulfonamide 7,7-dioxideMERCK & CO INC·Filed 1995·Granted Nov 18, 1997·14 cites·8 claims
- 2453US5011942AProcess for racemizing an enantiomer of 5,6-dihydro-4-alkylamino-4H-thieno(or furo) [2,3-B]-thiopyran-2-sulfonamide-7,7-dioxideMERCK & CO INC·Filed 1990·Granted Apr 30, 1991·4 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Thomas J. Blacklock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →